Clinical Trial Update: Controlling Hyperadrenergic Activity in Neurologic Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial on controlling hyperadrenergic activity in neurologic injury sponsored by Johns Hopkins University has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysautonomia
• Traumatic Brain Injury

Snippet

Sponsor: Johns Hopkins University | Conditions: Traumatic Brain Injury, Dysautonomia | Phase 1, Phase 2 | Status: WITHDRAWN